Reversal of Pulmonary Hypertension in a Human-Like Model: Therapeutic Targeting of Endothelial DHFR.

Authors:
Murugesan P; Zhang Y; Huang Y; Chenggong Zong N; Youn JY and 4 more

Journal:
Circ Res

Publication Year: 2024

DOI:
10.1161/CIRCRESAHA.123.323090

PMCID:
PMC10880947

PMID:
38299369

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Circ Res

Abbreviation: Circ Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Vascular Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Directional Endothelial Communication by Polarized Extracellular Vesicle Release.
Raju S; Botts SR; Blaser MC and 16 more (2024) - Transparency Score: 4/6
Sox9 Accelerates Vascular Aging by Regulating Extracellular Matrix Composition and Stiffness.
Faleeva M; Ahmad S; Theofilatos K and 7 more (2024) - Transparency Score: 4/6
Cardiac Alternans: From Bedside to Bench and Back.
Qu Z; Weiss JN. (2023) - Transparency Score: 3/6
Cardiovascular Calcification Heterogeneity in Chronic Kidney Disease.
Hutcheson JD; Goettsch C. (2023) - Transparency Score: 3/6
Cell-Specific Mechanisms in the Heart of COVID-19 Patients.
Tsai EJ; Cˇiháková D; Tucker NR. (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosures None."

Evidence found in paper:

"Sources of Funding This work was supported by the National Heart, Lung, and Blood Institute grants HL077440 (to H. Cai), HL088975 (to H. Cai), HL142951 (to H. Cai), HL154754 (to H. Cai and A.M.), HL162407 (to H. Cai and J.G.), HL142951-03S1 (to H. Cai), and HL154754-03S1 (to H. Cai)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025